# MASSACHUSETTS GENERAL HOSPITAL: Small molecule PTH1R inverse agonists as a therapy for Jansen's Metaphyseal Chondrodysplasia

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | MASSACHUSETTS GENERAL HOSPITAL |
| Location | BOSTON, MA |
| Project | Small molecule PTH1R inverse agonists as a therapy for Jansen's Metaphyseal Chondrodysplasia |
| Project number | 1R21HD123465-01 |
| Mechanism | R21 |
| Institute | Eunice Kennedy Shriver National Institute of Child Health and Human Development |
| Award | $435,794 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-20 to 2028-09-19 |
| UEI | FLJ7DQKLL226 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11439472). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.